Alert detail
FDA Approval: ARIKAYCE (AMIKACIN) — Type 3 - New Dosage Form
Policy ID: FDA-NDA207356Specialty: PulmonologyAdded: 7/1/2026Effective: 2018-09-28billing update
Full alert analysis requires a subscription
Subscribe to access the complete alert summary, AI-generated action recommendations, source document links, LCD revision comparisons, and related alerts.